Comment by
subaru1i on Apr 18, 2024 9:07pm
Wonder what will come first, Q1 earnings or FDA approvals on the ANDA and 505(b)2? F--- Tr-----!!! ps: One thing you don't say when surrounded by loaded 12 gauge shotguns at a gun club...."Trudea is the best"....LOL
Comment by
unplugged1 on Apr 19, 2024 12:04pm
should be good and another feather in the cap is that the german government covers the cost of medical Rx, 100% - maybe a close second in wicked! next to the legalization.
Comment by
unplugged1 on Apr 19, 2024 12:09pm
should be good and another feather in the cap is that the german government covers the cost of medical Rx, 100% - maybe a close second in wicked! next to the legalization.
Comment by
alleyesonme on Apr 19, 2024 1:46pm
Huge.... additionally the global dronabinol shortage puts MPL capabilities in high demand, capitalizing on this in a big way. https://www.stockwatch.com/News/Item/Z-C!LABS-3528103/C/LABS
Comment by
subaru1i on Apr 19, 2024 2:59pm
CEO did say back in 2023 they were targeting Q1, 2024 as becoming a profitable company.